B-cell NHL
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety, Tolerability, Pharmacokinetics and Efficacy Study of GB261 in B-Cell NHL and CLL. (NCT04923048) | Genor Biopharma Co., Ltd. | 2021-08-31 |
| Safety Study of NHL With 90Y-hLL2 IgG (NCT00421395) | Gilead Sciences | 2002-08-01 |
Track B-cell NHL automatically
Every clearance here is in the API, with alerts when new ones post.